The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 7,425 | 1,455,904 | SH | SOLE | 1,455,904 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 10,176 | 1,356,813 | SH | SOLE | 1,356,813 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 12,637 | 1,599,592 | SH | SOLE | 1,599,592 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 42,231 | 1,018,362 | SH | SOLE | 1,018,362 | 0 | 0 | ||
INVUITY INC | COM | 46187J205 | 7,832 | 1,080,272 | SH | SOLE | 1,080,272 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,428 | 329,942 | SH | SOLE | 329,942 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 18,811 | 1,074,316 | SH | SOLE | 1,074,316 | 0 | 0 | ||
MEI PHARMA INC | COM | 55279B202 | 1,387 | 580,401 | SH | SOLE | 580,401 | 0 | 0 | ||
OBALON THERAPEUTICS INC | COM | 67424L100 | 24,313 | 2,453,338 | SH | SOLE | 2,453,338 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 12,348 | 512,366 | SH | SOLE | 512,366 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 282,760 | 2,021,738 | SH | SOLE | 2,021,738 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 26 | 8,293 | SH | SOLE | 8,293 | 0 | 0 |